Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer’s disease on Aβ1-40 peptide early assembly
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-2650
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer’s disease on Aβ1-40 peptide early assembly ; volume:411 ; number:24 ; day:12 ; month:8 ; year:2019 ; pages:6353-6363 ; date:9.2019
Analytical and bioanalytical chemistry ; 411, Heft 24 (12.8.2019), 6353-6363, 9.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00216-019-02030-7
- URN
-
urn:nbn:de:101:1-2020011512244072110328
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lazzaro, Serena
- Ogrinc, Nina
- Lamont, Lieke
- Vecchio, Graziella
- Pappalardo, Giuseppe
- Heeren, Ron M.A.
- SpringerLink (Online service)
Other Objects (12)
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
Revealing post-transcriptional microRNA–mRNA regulations in Alzheimer’s disease through ensemble graphs
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum
Raman spectroscopy and multivariate analysis as potential tool to follow Alzheimer’s disease progression
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
Revealing post-transcriptional microRNA–mRNA regulations in Alzheimer’s disease through ensemble graphs
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum
Raman spectroscopy and multivariate analysis as potential tool to follow Alzheimer’s disease progression
Revealing Alzheimer’s disease genes spectrum in the whole-genome by machine learning
Alzheimer’s disease candidate gene PION is differentially expressed in human prefrontal cortex
Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
Revealing post-transcriptional microRNA–mRNA regulations in Alzheimer’s disease through ensemble graphs
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum